Cited by

• Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease.

  Damle RN, Tatake RJ, Advani SH, Gangal SG. Damle RN, et al. Br J Cancer. 1990 Mar;61(3):404-6. doi: 10.1038/bjc.1990.88. Br J Cancer. 1990. PMID: 2328206 Free PMC article. No abstract available.
• Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies.

  Mantovani G, Macciò A, Astara G, Contini L, Esu S, Littera S, Arangino V, Lai P, Proto E, Pusceddu G, et al. Mantovani G, et al. Cell Biophys. 1993 Jan-Jun;22(1-3):79-99. doi: 10.1007/BF03033868. Cell Biophys. 1993. PMID: 7889544
• Lectin activity as a marker for Hodgkin disease cells.

  Paietta E, Stockert RJ, Morell AG, Diehl V, Wiernik PH. Paietta E, et al. Proc Natl Acad Sci U S A. 1986 May;83(10):3451-5. doi: 10.1073/pnas.83.10.3451. Proc Natl Acad Sci U S A. 1986. PMID: 2422650 Free PMC article.
• Intrinsic B lymphocyte defect in untreated patients with Hodgkin's disease.

  Griesinger F, Bergmann L, Barot-Ciorbaru R, Mitrou PS. Griesinger F, et al. Cancer Immunol Immunother. 1990;32(4):256-60. doi: 10.1007/BF01741710. Cancer Immunol Immunother. 1990. PMID: 2261600 Free PMC article.
• Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.

  Rajaram N, Tatake RJ, Advani SH, Gangal SG. Rajaram N, et al. Br J Cancer. 1990 Aug;62(2):205-8. doi: 10.1038/bjc.1990.261. Br J Cancer. 1990. PMID: 2386735 Free PMC article.